-
Product Insights
NewLikelihood of Approval Analysis for Allergic Asthma
Overview How likely is it that the drugs in Allergic Asthma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergic Asthma Overview Allergic asthma is a type of asthma triggered by...
-
Product Insights
NewLikelihood of Approval Analysis for Conjunctivitis
Overview How likely is it that the drugs in Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Conjunctivitis Overview Conjunctivitis, commonly known as "pink eye", refers to inflammation of the...
-
Product Insights
NewLikelihood of Approval Analysis for Mycosis Fungoides
Overview How likely is it that the drugs in Mycosis Fungoides will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycosis Fungoides Overview Mycosis fungoides is a rare type of non-Hodgkin lymphoma,...
-
Product Insights
Ia Pet – Dak Doa Wind Farm
Ia Pet - Dak Doa Wind Farm is an onshore wind project located in Gia Lai, Vietnam. The project came online in 2021. Empower your strategies with our Ia Pet - Dak Doa Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Analyst Opinions
NewUnited Kingdom (UK) Personal Lines Insurance Distribution Dynamics and Future Market, 2023 Update
United Kingdom (UK) Personal Lines Insurance Market Report Overview The direct channel was the preferred choice for personal insurance purchases in the UK in 2023. Consumers are increasingly opting for online insurance purchases driving insurers and distributors to continue enhancing their online capabilities. Consumers prioritize affordability and trustworthiness when selecting an insurance provider, regardless of distribution channel. Hence, across all lines of distribution, the primary factors influencing consumers’ choice is either related to the cost of premiums or the provider’s...
-
Sector Analysis
NewPlastics Market Analysis and Forecast by Products, Capacity Additions, Top Countries and Active and Upcoming Projects to 2030
Plastics Market Report Overview The plastics market has shown robust and consistent growth and is projected to record a healthy CAGR of 2% during 2024-2030. Constantly evolving lifestyles, the growth of the retail sector, and the increasing construction activities in emerging countries are the factors driving the plastics market growth. Asia continues to dominate global plastics consumption due to rapid economic growth in China, India, South Korea, and Japan. Plastics Market Analysis by Regions, 2023 (%) Buy the Full Report...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bomedemstat Tosylate in Myelofibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bomedemstat Tosylate in Myelofibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bomedemstat Tosylate in Myelofibrosis Drug Details: IMG-7289 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bomedemstat Tosylate in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bomedemstat Tosylate in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bomedemstat Tosylate in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bomedemstat Tosylate in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bomedemstat Tosylate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bomedemstat Tosylate in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bomedemstat Tosylate in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bomedemstat Tosylate in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bomedemstat Tosylate in Refractory Acute Myeloid Leukemia Drug Details:...